From Europe. For the global patent community.
Trending Topics:
JUVE Patent Supplementary protection certificates

Supplementary protection certificates

Cases
Pharmaceuticals

Sales ban: Teva successful against Mylan drug Clift

In an urgent ruling of Düsseldorf Regional Court (case ID: 4c O 22/19), Mylan has been issued a Clift sales ban in Germany. Clift is a generic product ...

19 June 2019 by Mathieu Klos
Cases
Arrow declarations

Dutch court confirms jurisdiction for arrow declarations

The District Court in the Hague has ruled in favour of Pfizer in a judgment concerning jurisdiction of arrow declarations. This is the first such juri ...

31 May 2019 by Amy Sandys
People & Business
Interview

“The UPC has the support of UK judges” - an interview with David Kitchin

Before his appointment as a Supreme Court judge, David Kitchin presided over the global licence decided in the Unwired Planet vs. Huawei case at the C ...

17 May 2019 by Amy Sandys
Legal Commentary
SPCs

European Commission passes SPC waiver

In May 2018, the European Commission published a proposal to introduce an SPC manufacturing waiver for export purposes. This has now been passed. It w ...

24 April 2019 by Amy Sandys
Cases
SPC law

Generics manufacturers prevail over Hogan Lovells client MSD

Various generics manufacturers have won in the second instance in the dispute over supplementary protection certificates for cholesterol-lowering drug ...

19 March 2019 by Konstanze Richter
Legal Commentary
Supplementary protection certificates

SPC waiver subject to debate

It was planned for the SPC manufacturing waiver to be introduced in the EU before 2019. However, the final report by the Committee for Legal Affairs ( ...

11 February 2019 by Amy Sandys
Cases
Breast cancer drug

High Court upholds Novartis infringement application

Global healthcare company Novartis has won a High Court judgment against Dr Reddy’s Laboratories over a treatment for breast cancer. An interim injunc ...

28 January 2019 by Amy Sandys
Legal Commentary
SPC law

At a dead end

Rapid innovation and conflicting interests in the pharmaceutical industry are causing trouble for the outdated EU regulation on the supplementary prot ...

24 September 2018 by Mathieu Klos
Popular